Michio Mizobe

Clinical Features and Prognosis of Patients With Coronary Spasm–Induced Non–ST‐Segment Elevation Acute Coronary Syndrome

Naoki Nakayama, Koichi Kaikita, Takashi Fukunaga et al. · Journal of the American Heart Association · 2014 · 58 citations · Full text

Medicine, Cardiology, Internal Medicine +15

Impact of CYP2C19 Polymorphism and Proton Pump Inhibitors on Platelet Reactivity to Clopidogrel and Clinical Outcomes Following Stent Implantation

Seiji Hokimoto, Michio Mizobe, Tomonori Akasaka et al. · Thrombosis Research · 2014 · 49 citations

Medicine, Pharmacology, Pharmacotherapy +17

Clinical Outcomes Following Coronary Stenting in Japanese Patients Treated With and Without Proton Pump Inhibitor

Tadasuke Chitose, Seiji Hokimoto, Shuichi Oshima et al. · Circulation Journal · 2011 · 32 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Impact of CYP2C19 polymorphism on clinical outcome following coronary stenting is more important in non-diabetic than diabetic patients

Michio Mizobe, Seiji Hokimoto, Tomonori Akasaka et al. · Thrombosis Research · 2014 · 15 citations

Medicine, Cardiology, Clinical Cardiology +16

Comprehensive analysis of intravascular ultrasound and angiographic morphology of culprit lesions between ST-segment elevation myocardial infarction and non-ST-segment elevation acute coronary syndrome

Naoko Takaoka, Kenichi Tsujita, Koichi Kaikita et al. · International Journal of Cardiology · 2014 · 13 citations

Medicine, Cardiology, Internal Medicine +17